Oncoceutics, Inc.
Industry
- Biotechnology
- Drug Discovery Technologies
- ADMET
- Drug Discovery Technologies
- Pharmaceuticals
Other Names/Subsidiaries
- Chimerix, Inc.
Latest on Oncoceutics, Inc.
The Dutch firm argenx N.V. closed a follow-on public offering (FOPO) in the US and concurrent private placement of ordinary shares in Europe on 4 February that grossed $1.15bn to fund the company’s
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sanofi Backs Biond's IO Agent With Big
The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer
The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer